Biomarkers Market Report 2030: Key Insights You Need to Know

The global Biomarkers Market, valued at USD 67.70 billion in 2024, is projected to reach USD 133.51 billion by 2030, with a CAGR of 11.9% from 2025 to 2030.

Download FREE Sample

 North America dominates the market and is expected to maintain its lead, driven by the increasing adoption of biomarkers to reduce risks associated with laboratory-developed tests.

 Key players are focusing on enhancing the precision, accessibility, and scope of diagnostic tools through advancements in high-sensitivity biomarker assays, AI-driven diagnostics, and multi-biomarker panels, which complement traditional methods to improve early detection and personalized treatment outcomes, thereby capturing greater market share and leveraging significant growth potential